Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 6/20 | 0.33 |
| ▸ | RXRB | P28702 | 2/20 | 0.33 |
| ▸ | RXRG | P48443 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 4/20 | 0.32 |
| ▸ | HTR7 | P34969 | 4/20 | 0.32 |
| ▸ | HTR6 | P50406 | 4/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.32 |
| ▸ | CYP26B1 | Q9NR63 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26004023 | 0.92 | CYP1A2 (0.32) | HTR1AHTR7HTR6CYP1A2CYP2D6 | |
| SCHEMBL16806186 | 0.82 | ESR1 (0.41) | HTR1AHTR7HTR6CYP1A2CYP2D6 | |
| SCHEMBL25037670 | 0.82 | ESR1 (0.43) | CYP1A2CYP2D6CYP2C19ESR1 | |
| SCHEMBL19274922 | 0.79 | CYP1A2 (0.41) | HTR1AHTR7HTR6CYP1A2CYP2D6 | |
| SCHEMBL26000651 | 0.78 | PON1 (0.40) | RXRARXRBRXRGRARACYP26A1 | |
| SCHEMBL26014567 | 0.75 | CYP26A1 (0.33) | RXRARXRBRXRGCYP26A1CYP26B1 | |
| SCHEMBL31145722 | 0.75 | RXRA (0.33) | RXRARXRBRXRGRARA | |
| SCHEMBL24807980 | 0.75 | AHR (0.54) | RXRA | |
| SCHEMBL26003561 | 0.74 | KDM4E (0.37) | HTR1AHTR7HTR6CYP1A2CYP2D6 | |
| SCHEMBL13111861 | 0.74 | CYP1A2 (0.55) | CYP1A2CYP2D6CYP2C19CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-20230265063-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265063-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | PIEZO1, OR10J3, OR51E2 | RXRA 2012/4885RXRB 2635/4885RXRG 2532/4885 |
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | PIEZO1, OR10J3, OR51E2 | RXRA 2012/4885RXRB 2635/4885RXRG 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.